IDXG Fundamental Analysis - Interpace Diag Group

No Fundamental Analysis report for IDXG not available.

Interpace Diag Group

NASDAQ:IDXG (2/24/2021, 8:13:19 PM)

After market: 3.76 -0.16 (-4.08%)

3.92

+0.02 (+0.51%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)03-29 2022-03-29

Earnings (Next)05-09 2022-05-09

Inst Owners6.67%

Inst Owner Change0%

Ins Owners25.2%

Ins Owner Change0%

Market Cap16.09M

Revenue(TTM)26.97M

Net Income(TTM)-28.80M

Analysts100

Price TargetN/A

Short Float %0.02%

Short Ratio0

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.6
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	-0.64

EPS(TTM)-4.94

EYN/A

EPS(NY)-1.62

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS6.57

BVpS-5.31

TBVpSN/A

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-56.81%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	-106.54%
PM (TTM)	-106.8%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3Y0%

ROICexgc growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score2

Asset Turnover0.53

Health

		Industry Rank	Sector Rank
Debt/Equity	-0.16
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.13
Quick Ratio	1.13
Altman-Z	-6.78

F-Score2

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-25.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.41%

EPS Next Y-33000%

EPS Next 2Y-16462.24%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)4.37%

Revenue growth 3YN/A

Revenue growth 5Y23.38%

Sales Q2Q%6.77%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

Interpace Diag Group / IDXG FAQ

Can you provide the ChartMill fundamental rating for Interpace Diag Group?

ChartMill assigns a fundamental rating of 2 / 10 to IDXG.

Can you provide the valuation status for Interpace Diag Group?

ChartMill assigns a valuation rating of 0 / 10 to Interpace Diag Group (IDXG). This can be considered as Overvalued.

How profitable is Interpace Diag Group (IDXG) stock?

Interpace Diag Group (IDXG) has a profitability rating of 0 / 10.

How financially healthy is Interpace Diag Group?

The financial health rating of Interpace Diag Group (IDXG) is 2 / 10.

Is the dividend of Interpace Diag Group sustainable?

The dividend rating of Interpace Diag Group (IDXG) is 0 / 10 and the dividend payout ratio is 0%.

Interpace Diag Group (IDXG) Stock Fundamental Analysis